Session activity on Cymabay Therapeutics, Inc.(NASDAQ:CBAY) shares bumps the stock on today’s most active list. After a recent spot-check, the stock has touched $6.29 which represents a change from the open of -9.50%. Company shares have been seen trading 4.49% off of the 52 week high and 446.96% away from the 52 week low. Narrowing in, the stock is at a distance of 4.49% from the 50 day high and 97.69% off of the 50 day low.Covering sell-side analysts have recently weighed in on shares of Cymabay Therapeutics, Inc. (NASDAQ:CBAY). At the time of writing, the First Call consensus price target for the company is $8.79. The current consensus recommendation provided by covering analysts is 1.60. This recommendation lands on a scale between 1 and 5. Analysts giving shares a rating of 1 or 2 would be indicating a Buy. A rating of 4 or 5 would represent a Sell recommendation. Analysts pegging the company with a rating of 3 would be indicating a Hold recommendation.
Since the beginning of the calendar year, the stock is 226.59%. For the quarter, shares have been noted at 33.89%. Share performance for the month is currently at 23.36%. Tightening the gaze, stock performance for the last 5 trading days is 0.00%.